Characterization of anti-porcine epidemic diarrhea virus neutralizing activity in mammary secretions

Virus Research

Volumn 226, Issue , 2016, Pages 85-92

  Song, Qinye ^a   Stone, Suzanne ^a   Drebes, Donna ^a   Greiner, Laura L ^b   Dvorak, Cheryl M T ^a   Murtaugh, Michael P ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b CARTHAGE VETERINARY SERVICE LTD   (United States)

Author keywords

Anti PEDV IgA; Colostrum and milk; Correlation; Dynamics; Neutralizing activity; PEDV

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS SPIKE PROTEIN; CORONAVIRUS SPIKE GLYCOPROTEIN; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COLOSTRUM; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOFLUORESCENCE; KINETICS; LACTATION; MILK; NONHUMAN; PORCINE EPIDEMIC DIARRHEA VIRUS; PRIORITY JOURNAL; SERUM; SOW (SWINE); VIRUS NEUTRALIZATION; ANIMAL; BLOOD; CHLOROCEBUS AETHIOPS; CORONAVIRUS INFECTION; FEMALE; IMMUNOLOGY; PIG; SERODIAGNOSIS; SWINE DISEASE; VERO CELL LINE; VETERINARY; VIROLOGY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CERCOPITHECUS AETHIOPS; CORONAVIRUS INFECTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LACTATION; MILK; NEUTRALIZATION TESTS; PORCINE EPIDEMIC DIARRHEA VIRUS; SPIKE GLYCOPROTEIN, CORONAVIRUS; SWINE; SWINE DISEASES; VERO CELLS;

EID: 84994319081     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2016.06.002     Document Type: Article

References (51)

1. Andrewes, C.H., Elford, W.J., Observations on anti-phage sera. I. The percentage law. Br. J. Exp. Pathol. 14:6 (1933), 367–376.
2. Annamalai, T., Saif, L.J., Lu, Z., Jung, K., Age-dependent variation in innate immune responses to porcine epidemic diarrhea virus infection in suckling versus weaned pigs. Vet. Immunol. Immunopathol. 168:3–4 (2015), 193–202.
3. Anon, U.S.D.o. Agriculture, (eds.) Swine Enteric Coronavirus Disease Tessting Summary Report, July 24, 2014, 2014, US Government Printing Office, Washington, DC, 1–33.
4. Arndt, A.L., Larson, B.J., Hogue, B.G., A conserved domain in the coronavirus membrane protein tail is important for virus assembly. J. Virol. 84:21 (2010), 11418–11428.
5. Brioen, P., Boeye, A., Poliovirus neutralization and the percentage law. Brief report. Arch. Virol. 83:1–2 (1985), 105–111.
6. Chattha, K.S., Roth, J.A., Saif, L.J., Strategies for design and application of enteric viral vaccines. Annu. Rev. Anim. Biosci. 3 (2015), 375–395.
7. Chen, J., Wang, C., Shi, H., Qiu, H.J., Liu, S., Shi, D., Zhang, X., Feng, L., Complete genome sequence of a Chinese virulent porcine epidemic diarrhea virus strain. J. Virol. 85:21 (2011), 11538–11539.
8. Chen, Q., Li, G., Stasko, J., Thomas, J.T., Stensland, W.R., Pillatzki, A.E., Gauger, P.C., Schwartz, K.J., Madson, D., Yoon, K.J., Stevenson, G.W., Burrough, E.R., Harmon, K.M., Main, R.G., Zhang, J., Isolation and characterization of porcine epidemic diarrhea viruses associated with the 2013 disease outbreak among swine in the United States. J. Clin. Microbiol. 52:1 (2014), 234–243.
9. Cima, G., Viral disease affects U.S. pigs: porcine epidemic diarrhea found in at least 11 states. J. Am. Vet. Med. Assoc. 243:1 (2013), 30–31.
10. Cruz, D.J., Kim, C.J., Shin, H.J., The GPRLQPY motif located at the carboxy-terminal of the spike protein induces antibodies that neutralize Porcine epidemic diarrhea virus. Virus Res. 132:1–2 (2008), 192–196.
11. Dvorak, C.M.T., Yang, Y., Haley, C., Sharma, N., Murtaugh, M.P., National reduction in porcine circovirus type 2 prevalence following introduction of vaccination. Vet. Microbiol. 189 (2016), 86–90.
12. Goede, D., Murtaugh, M.P., Nerem, J., Yeske, P., Rossow, K., Morrison, R., Previous infection of sows with a mild strain of porcine epidemic diarrhea virus confers protection against infection with a severe strain. Vet. Microbiol. 176:1–2 (2015), 161–164.
13. Johnson, C.R., Yu, W., Murtaugh, M.P., Cross-reactive antibody responses to nsp1 and nsp2 of Porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 88:Pt 4 (2007), 1184–1195.
14. Klasse, P.J., Moore, J.P., Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1. J. Virol. 70:6 (1996), 3668–3677.
15. Klasse, P.J., Sattentau, Q.J., Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J. Gen. Virol. 83:Pt 9 (2002), 2091–2108.
16. Kocherhans, R., Bridgen, A., Ackermann, M., Tobler, K., Completion of the porcine epidemic diarrhoea coronavirus (PEDV) genome sequence. Virus Genes 23:2 (2001), 137–144.
17. Kweon, C.H., Kwon, B.J., Lee, J.G., Kwon, G.O., Kang, Y.B., Derivation of attenuated porcine epidemic diarrhea virus (PEDV) as vaccine candidate. Vaccine 17:20–21 (1999), 2546–2553.
18. Lee, D.K., Park, C.K., Kim, S.H., Lee, C., Heterogeneity in spike protein genes of porcine epidemic diarrhea viruses isolated in Korea. Virus Res. 149:2 (2010), 175–182.
19. Li, J., Murtaugh, M.P., Dissociation of porcine reproductive and respiratory syndrome virus neutralization from antibodies specific to major envelope protein surface epitopes. Virology 433 (2012), 367–376.
20. Li, W., Li, H., Liu, Y., Pan, Y., Deng, F., Song, Y., Tang, X., He, Q., New variants of porcine epidemic diarrhea virus, China, 2011. Emerg. Infect. Dis. 18:8 (2012), 1350–1353.
21. Liu, D.Q., Ge, J.W., Qiao, X.Y., Jiang, Y.P., Liu, S.M., Li, Y.J., High-level mucosal and systemic immune responses induced by oral administration with Lactobacillus-expressed porcine epidemic diarrhea virus (PEDV) S1 region combined with Lactobacillus-expressed N protein. Appl. Microbiol. Biotechnol. 93:6 (2012), 2437–2446.
22. Madson, D.M., Magstadt, D.R., Arruda, P.H., Hoang, H., Sun, D., Bower, L.P., Bhandari, M., Burrough, E.R., Gauger, P.C., Pillatzki, A.E., Stevenson, G.W., Wilberts, B.L., Brodie, J., Harmon, K.M., Wang, C., Main, R.G., Zhang, J., Yoon, K.J., Pathogenesis of porcine epidemic diarrhea virus isolate (US/Iowa/18984/2013) in 3-week-old weaned pigs. Vet. Microbiol. 174:1–2 (2014), 60–68.
23. McEwan, W.A., Hauler, F., Williams, C.R., Bidgood, S.R., Mallery, D.L., Crowther, R.A., James, L.C., Regulation of virus neutralization and the persistent fraction by TRIM21. J. Virol. 86:16 (2012), 8482–8491.
24. Moon, H.W., Norman, J.O., Lambert, G., Age dependent resistance to transmissible gastroenteritis of swine (TGE). I. Clinical signs and some mucosal dimensions in small intestine. Can. J. Comp. Med. 37:2 (1973), 157–166.
25. Nishimura, Y., Igarashi, T., Haigwood, N., Sadjadpour, R., Plishka, R.J., Buckler-White, A., Shibata, R., Martin, M.A., Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies. J. Virol. 76:5 (2002), 2123–2130.
26. Norman, J.O., Lambert, G., Moon, H.W., Stark, S.L., Age dependent resistance to transmissible gastroenteritis of swine (TGE). II. Coronavirus titer in tissues of pigs after exposure. Can. J. Comp. Med. 37:2 (1973), 167–170.
27. Oh, J., Lee, K.W., Choi, H.W., Lee, C., Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein. Arch. Virol. 159:11 (2014), 2977–2987.
28. Ouyang, K., Shyu, D.L., Dhakal, S., Hiremath, J., Binjawadagi, B., Lakshmanappa, Y.S., Guo, R., Ransburgh, R., Bondra, K.M., Gauger, P., Zhang, J., Specht, T., Gilbertie, A., Minton, W., Fang, Y., Renukaradhya, G.J., Evaluation of humoral immune status in porcine epidemic diarrhea virus (PEDV) infected sows under field conditions. Vet. Res., 46(1), 2015, 140.
29. Park, S.J., Song, D.S., Park, B.K., Molecular epidemiology and phylogenetic analysis of porcine epidemic diarrhea virus (PEDV) field isolates in Korea. Arch. Virol. 158:7 (2013), 1533–1541.
30. Paudel, S., Park, J.E., Jang, H., Hyun, B.H., Yang, D.G., Shin, H.J., Evaluation of antibody response of killed and live vaccines against porcine epidemic diarrhea virus in a field study. Vet. Q. 34:4 (2014), 194–200.
31. Pensaert, M.B., de Bouck, P., A new coronavirus-like particle associated with diarrhea in swine. Arch. Virol. 58:3 (1978), 243–247.
32. Pijpers, A., van Nieuwstadt, A.P., Terpstra, C., Verheijden, J.H., Porcine epidemic diarrhoea virus as a cause of persistent diarrhoea in a herd of breeding and finishing pigs. Vet. Rec. 132:6 (1993), 129–131.
33. Puvanendiran, S., Stone, S., Yu, W., Johnson, C.R., Abrahante, J., Jimenez, L.G., Griggs, T., Haley, C., Wagner, B., Murtaugh, M.P., Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV 2 exposure and infection in swine finisher herds. Virus Res. 157:1 (2011), 92–98.
34. Reverberi, R., Reverberi, L., Factors affecting the antigen-antibody reaction. Blood Transfus. 5:4 (2007), 227–240.
35. Robinson, S.R., Figueiredo, M.C., Abrahante, J.E., Murtaugh, M.P., Immune response to ORF5a protein immunization is not protective against porcine reproductive and respiratory syndrome virus infection. Vet. Microbiol. 164:3–4 (2013), 281–285.
36. Roehrig, J.T., Hombach, J., Barrett, A.D., Guidelines for plaque-reduction neutralization testing of human antibodies to dengue viruses. Viral Immunol. 21:2 (2008), 123–132.
37. Saif, L.J., Coronavirus immunogens. Vet. Microbiol. 37:3–4 (1993), 285–297.
38. Schwartz, E.J., Smith, R.J., Identifying the conditions under which antibodies protect against infection by equine infectious anemia virus. Vaccines (Basel) 2:2 (2014), 397–421.
39. Shingai, M., Donau, O.K., Plishka, R.J., Buckler-White, A., Mascola, J.R., Nabel, G.J., Nason, M.C., Montefiori, D., Moldt, B., Poignard, P., Diskin, R., Bjorkman, P.J., Eckhaus, M.A., Klein, F., Mouquet, H., Cetrulo Lorenzi, J.C., Gazumyan, A., Burton, D.R., Nussenzweig, M.C., Martin, M.A., Nishimura, Y., Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques. J. Exp. Med. 211:10 (2014), 2061–2074.
40. Song, D., Park, B., Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines. Virus Genes 44:2 (2012), 167–175.
41. Song, D.S., Oh, J.S., Kang, B.K., Yang, J.S., Moon, H.J., Yoo, H.S., Jang, Y.S., Park, B.K., Oral efficacy of Vero cell attenuated porcine epidemic diarrhea virus DR13 strain. Res. Vet. Sci. 82:1 (2007), 134–140.
42. Stevenson, G.W., Hoang, H., Schwartz, K.J., Burrough, E.R., Sun, D., Madson, D., Cooper, V.L., Pillatzki, A., Gauger, P., Schmitt, B.J., Koster, L.G., Killian, M.L., Yoon, K.J., Emergence of Porcine epidemic diarrhea virus in the United States: clinical signs, lesions, and viral genomic sequences. J. Vet. Diagn. Invest. 25:5 (2013), 649–654.
43. Sun, D., Feng, L., Shi, H., Chen, J., Cui, X., Chen, H., Liu, S., Tong, Y., Wang, Y., Tong, G., Identification of two novel B cell epitopes on porcine epidemic diarrhea virus spike protein. Vet. Microbiol. 131:1–2 (2008), 73–81.
44. To, K.K., Zhang, A.J., Hung, I.F., Xu, T., Ip, W.C., Wong, R.T., Ng, J.C., Chan, J.F., Chan, K.H., Yuen, K.Y., High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clin. Vaccine Immunol. 19:7 (2012), 1012–1018.
45. Tyrrell, D.A., Neutralization of viruses by homologous immune serum. II. Theoretical study of the equilibrium state. J. Exp. Med. 97:6 (1953), 863–870.
46. Vlasova, A.N., Marthaler, D., Wang, Q., Culhane, M.R., Rossow, K.D., Rovira, A., Collins, J., Saif, L.J., Distinct characteristics and complex evolution of PEDV strains, North America, May 2013-February 2014. Emerg. Infect. Dis., 20(10), 2014.
47. Wesley, R.D., Lager, K.M., Increased litter survival rates, reduced clinical illness and better lactogenic immunity against TGEV in gilts that were primed as neonates with porcine respiratory coronavirus (PRCV). Vet. Microbiol. 95:3 (2003), 175–186.
48. Willey, R., Nason, M.C., Nishimura, Y., Follmann, D.A., Martin, M.A., Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay. AIDS Res. Hum. Retrovir. 26:1 (2010), 89–98.
49. Wood, E.N., An apparently new syndrome of porcine epidemic diarrhoea. Vet. Rec. 100:12 (1977), 243–244.
50. Yang, X., Huo, J.Y., Chen, L., Zheng, F.M., Chang, H.T., Zhao, J., Wang, X.W., Wang, C.Q., Genetic variation analysis of reemerging porcine epidemic diarrhea virus prevailing in central China from 2010 to 2011. Virus Genes 46:2 (2013), 337–344.
51. Zhang, Z., Chen, J., Shi, H., Chen, X., Shi, D., Feng, L., Yang, B., Identification of a conserved linear B-cell epitope in the M protein of porcine epidemic diarrhea virus. Virol. J., 9, 2012, 225.